Neoadjuvant chemoradiotherapy

You have access
Metabolomics-based Discovery of Serum Biomarkers to Predict the Side-effects of Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
SHIN NISHIUMI, SEIJI FUJIGAKI, TAKASHI KOBAYASHI, TAKASHI KOJIMA, YOSHINORI ITO, HIROYUKI DAIKO, KEN KATO, HIROKAZU SHOJI, YUZO KODAMA, KAZUFUMI HONDA and MASARU YOSHIDA

Anticancer Research January 2019, 39 (1) 519-526; DOI: https://doi.org/10.21873/anticanres.13143
You have access
Neoadjuvant Chemotherapy Versus Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma
YUICHIRO NAKASHIMA, HIROSHI SAEKI, QINGJIANG HU, YASUO TSUDA, YUICHI HISAMATSU, KOJI ANDO, EIJI OKI and YOSHIHIKO MAEHARA

Anticancer Research December 2018, 38 (12) 6809-6814; DOI: https://doi.org/10.21873/anticanres.13053
You have access
Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic Esophagus
TAKAOKI FURUKAWA, YOICHI HAMAI, JUN HIHARA, MANABU EMI, ICHIKO YAMAKITA, YUTA IBUKI, TOMOAKI KUROKAWA and MORIHITO OKADA

Anticancer Research September 2018, 38 (9) 5239-5245; DOI: https://doi.org/10.21873/anticanres.12848
You have access
Effect of Neoadjuvant Chemoradiotherapy on Lymph Node Micrometastases in Thoracic Esophageal Cancer
MASAYUKI YANAGI, KEN SASAKI, YASUTO UCHIKADO, ITARU OMOTO, TAKAAKI ARIGAMI, HIROSHI KURAHARA, YOSHIKAZU UENOSONO, MASAHIKO SAKODA, KOSEI MAEMURA and SHOJI NATSUGOE

Anticancer Research February 2018, 38 (2) 893-900;
You have access
Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer
SATORU MOTOYAMA, YUSUKE SATO, TOMOHIKO SASAKI, AKIYUKI WAKITA, YUTA KAWAKITA, JIAJIA LIU, YUSHI NAGAKI, HAJIME SAITO, KAZUHIRO IMAI, HAYATO KONNO, KAORI T. MIZUSAWA and YOSHIHIRO MINAMIYA

Anticancer Research October 2017, 37 (10) 5837-5843;
You have access
Metabolic Rather than Pathological Response to Preoperative Chemoradiotherapy Is a Stronger Predictor of Survival in cStage IIB-IV Esophageal Cancer
SATORU MOTOYAMA, YUSUKE SATO, KIYOTOMI MARUYAMA, SHUETSU USAMI, KEI YOSHINO, TOSHINOBU NAKATSU, TOMOHIKO SASAKI, AKIYUKI WAKITA, YUTA KAWAKITA, JIAJIA LIU, AKIRA ANBAI, KOUICHI ISHIYAMA, HAJIME SAITO and YOSHIHIRO MINAMIYA

Anticancer Research August 2017, 37 (8) 4189-4194;
You have access
Role of ¹⁸F-FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy
KEN SASAKI, YASUTO UCHIKADO, HIROSHI OKUMURA, ITARU OMOTO, YOSHIAKI KITA, TAKAAKI ARIGAMI, YOSHIKAZU UENOSONO, TETSUHIRO OWAKI, KOSEI MAEMURA and SHOJI NATSUGOE

Anticancer Research February 2017, 37 (2) 859-864;

Main menu

User menu

Search

Neoadjuvant chemoradiotherapy

Pages